Anesthetic Considerations for Basal Cell Carcinoma

Preoperative Assessment

The National Comprehensive Cancer Network recommends evaluating the location, size, and invasiveness of the basal cell carcinoma to determine the appropriate surgical approach and consequently the anesthetic requirements 1, 2
Assess for high-risk features such as large tumor size, location in high-risk areas, aggressive histologic subtypes, and perineural invasion 1, 3
Review any previous treatments for basal cell carcinoma, including prior surgeries, radiation therapy, or systemic treatments like hedgehog pathway inhibitors 4, 5
Screen for genetic conditions that predispose to skin cancer as these may affect treatment decisions and anesthetic planning 3

Local anesthesia is typically sufficient for curettage and electrodesiccation procedures, standard excision with 4-mm clinical margins, and small Mohs micrographic surgery cases 6, 7
Local anesthesia with monitored anesthesia care may be appropriate for extensive Mohs surgery, wide local excision with complex reconstruction, and procedures in sensitive areas 1, 7
Regional anesthesia may be considered for extensive procedures on extremities 7
General anesthesia is typically reserved for extensive surgical resections with complex reconstruction 2

Radiation therapy is typically performed as an outpatient procedure without anesthesia for non-surgical candidates 1, 3
Radiation therapy may require multiple treatment sessions and is contraindicated in patients with genetic conditions predisposing to skin cancer 3

Pain management is typically straightforward with oral analgesics for most basal cell carcinoma procedures 7
Consider the cosmetic and functional outcomes, particularly for facial procedures 1, 2
Arrange appropriate follow-up due to the risk of recurrence and development of new primary basal cell carcinomas 4

Underestimating procedure duration, especially for Mohs surgery, can affect anesthetic planning 7
Inadequate local anesthesia can occur if the infiltrative basal cell carcinoma extends beyond visible margins 7
Neglecting follow-up planning can lead to missed subsequent skin cancers in patients with basal cell carcinoma 4